The significance of screening for microvascular diseases in chinese community-based subjects with various metabolic abnormalities

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Pang, Can ^a   Jia, Lili ^a   Hou, Xuhong ^a   Gao, Xin ^b   Liu, Wei ^c   Bao, Yuqian ^a   Jia, Weiping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; CREATININE; GLUCOSE;

ADULT; ALBUMINURIA; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHINESE; COMMUNITY PROGRAM; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY DISEASE SEVERITY SCALE; DIET RESTRICTION; DISEASE ASSOCIATION; EYE PHOTOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; METABOLIC DISORDER; MICROANGIOPATHY; PATIENT CODING; PRACTICE GUIDELINE; RATING SCALE; RETINOPATHY; RISK ASSESSMENT; RISK FACTOR; URBAN POPULATION; WAIST CIRCUMFERENCE; AGED; CHINA; COMMUNITY CARE; HYPERTENSIVE RETINOPATHY; METABOLIC SYNDROME X; MIDDLE AGED; VASCULAR DISEASES;

AGED; ALBUMINURIA; CHINA; COMMUNITY HEALTH SERVICES; FEMALE; HUMANS; HYPERTENSIVE RETINOPATHY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; URBAN POPULATION; VASCULAR DISEASES;

EID: 84901293603     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097928     Document Type: Article

References (27)

1. Isomaa B, Henricsson M, Almgren P, Tuomi T, Taskinen MR, et al. (2001) The metabolic syndrome influences the risk of chronic complications in patients with type II diabetes. Diabetologia 44: 1148-1154. (Pubitemid 32842461)
2. Bonadonna RC, Cucinotta D, Fedele D, Riccardi G, Tiengo A (2006) The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from Metascreen, a multicenter diabetes clinic-based survey. Diabetes Care 29: 2701-2707. (Pubitemid 44912202)
3. Kilpatrick ES, Rigby AS, Atkin SL (2007) Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "double diabetes" in the Diabetes Control and Complications Trial. Diabetes Care 30: 707-712. (Pubitemid 46354357)
4. Costa LA, Canani LH, Lisboa HR, Tres GS, Gross JL (2004) Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in Type 2 diabetes. Diabet Med 21: 252-255. (Pubitemid 38299619)
5. Wong TY, Duncan BB, Golden SH, Klein R, Couper DJ, et al. (2004) Associations between the metabolic syndrome and retinal microvascular signs: the Atherosclerosis Risk In Communities study. Invest Ophthalmol Vis Sci 45: 2949-2954. (Pubitemid 39121821)
6. Wang JJ, Mitchell P, Leung H, Rochtchina E, Wong TY, et al. (2003) Hypertensive retinal vessel wall signs in a general older population: the Blue Mountains Eye Study. Hypertension 42: 534-541. (Pubitemid 37237350)
7. Abdul-Ghani M, Nawaf G, Nawaf F, Itzhak B, Minuchin O, et al. (2006) Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndrome. Isr Med Assoc J 8: 378-382. (Pubitemid 43986048)
8. Raman R, Gupta A, Pal SS, Ganesan S, Venkatesh K, et al. (2010) Prevalence of Metabolic Syndrome and its influence on microvascular complications in the Indian population with Type 2 Diabetes Mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular Genetic Study (SN-DREAMS, report 14). Diabetol Metab Syndr 2: 67.
9. Iwasaki T, Togashi Y, Ohshige K, Yoneda M, Fujita K, et al. (2008) Neither the presence of metabolic syndrome as defined by the IDF guideline nor an increased waist circumference increased the risk of microvascular or macrovascular complications in Japanese patients with type 2 diabetes. Diabetes Res Clin Pract 79: 427-432.
10. Kawasaki R, Tielsch JM, Wang JJ, Wong TY, Mitchell P, et al. (2008) The metabolic syndrome and retinal microvascular signs in a Japanese population: the Funagata study. Br J Ophthalmol 92: 161-166. (Pubitemid 351224086)
11. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, et al. (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735-2752. (Pubitemid 41532612)
12. Ford ES (2005) Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 28: 2745-2749.
13. Jia W, Gao X, Pang C, Hou X, Bao Y, et al. (2009) Prevalence and risk factors of albuminuria and chronic kidney disease in Chinese population with type 2 diabetes and impaired glucose regulation: Shanghai diabetic complications study (SHDCS). Nephrol Dial Transplant 24: 3724-3731.
14. Pang C, Jia L, Jiang S, Liu W, Hou X, et al. (2012) Determination of diabetic retinopathy prevalence and associated risk factors in Chinese diabetic and prediabetic subjects: Shanghai diabetic complications study. Diabetes Metab Res Rev 28: 276-283.
15. Davis JE, McDonald JM, Jarett L (1978) A high-performance liquid chromatography method for hemoglobin A1c. Diabetes 27: 102-107. (Pubitemid 8294834)
16. (2004) Metabolic syndrome study cooperation group of Chinese diabetes society. Suggestions about metabolic syndrome of Chinese diabetes society. Chin J Diab 12: 156-161.
17. Wilkinson CP, Ferris FL 3rd, Klein RE, Lee PP, Agardh CD, et al. (2003) Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110: 1677-1682. (Pubitemid 37025422)
18. Hanai K, Babazono T, Iwamoto Y (2008) Renal manifestations of metabolic syndrome in type 2 diabetes. Diabetes Res Clin Pract 79: 318-324.
19. Lu B, Wen J, Song XY, Dong XH, Yang YH, et al. (2007) High prevalence of albuminuria in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown. Diabetes Res Clin Pract 75: 184-192. (Pubitemid 44894601)
20. Jia WP, Xiang KS, Chen L, Lu JX, Wu YM (2002) Epidemiological study on obesity and its comorbidities in urban Chinese older than 20 years of age in Shanghai, China. Obes Rev 3: 157-165. (Pubitemid 34815234)
21. Bao Y, Lu J, Wang C, Yang M, Li H, et al. (2008) Optimal waist circumference cutoffs for abdominal obesity in Chinese. Atherosclerosis 201: 378-384.
22. Kshirsagar AV, Bomback AS, Bang H, Gerber LM, Vupputuri S, et al. (2008) Association of C-reactive protein and microalbuminuria (from the National Health and Nutrition Examination Surveys, 1999 to 2004). Am J Cardiol 101: 401-406. (Pubitemid 351175628)
23. Nakamura M, Onoda T, Itai K, Ohsawa M, Satou K, et al. (2004) Association between serum C-reactive protein levels and microalbuminuria: a population-based cross-sectional study in northern Iwate, Japan. Intern Med 43: 919-925. (Pubitemid 39534794)
24. Sabanayagam C, Lee J, Shankar A, Lim SC, Wong TY, et al. (2010) C-reactive protein and microalbuminuria in a multi-ethnic Asian population. Nephrol Dial Transplant 25: 1167-1172.
25. Jiang L, Huang W, Liang Y, Wang F, Duan X, et al. (2013) Metabolic syndrome, C-reactive protein and microalbuminuria in a rural Chinese population: a cross-sectional study. BMC Nephrol 14: 118.
26. Lim LS, Tai ES, Mitchell P, Wang JJ, Tay WT, et al. (2010) C-reactive protein, body mass index, and diabetic retinopathy. Invest Ophthalmol Vis Sci 51: 4458-4463.
27. van der Velde M, Bello AK, Brantsma AH, El Nahas M, Bakker SJ, et al. (2012) Do albuminuria and hs-CRP add to the International Diabetes Federation definition of the metabolic syndrome in predicting outcome? Nephrol Dial Transplant 27: 2275-2283.